H.ValentiL.HuY.-Y.et al (2024)
Shipping & Handling Upon Arrival Orders containing CJC No DAC Ipamorelin Spray ship with cold-chain packaging appropriate for peptide products
Fatigue is a reported side effect for some GLP-1 receptor agonists, particularly at higher doses used for weight management
Healthcare providers increasingly recognize that dietary modifications, including appropriate fiber intake, constitute an essential component of comprehensive treatment management rather than an optional consideration
Eligibility, covered presentations, prior authorization, and exclusions are specific to the program
Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing
